Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
about
Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort studyComparative Efficacy of Adding Sitagliptin to Metformin, Sulfonylurea or Dual Therapy: A Propensity Score-Weighted Cohort Study.Safety and effectiveness of insulin aspart in Basal-bolus regimens regardless of age: a1chieve study results.Understanding heterogeneity in response to antidiabetes treatment: a post hoc analysis using SIDES, a subgroup identification algorithm.Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type).A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis.Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Association between insulin-induced weight change and CVD mortality: Evidence from a historical cohort study of 18,814 patients in UK Primary Care.Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.Effectiveness of insulin therapy in people with Type 2 diabetes in the Hoorn Diabetes Care System.Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes.Can we predict success of insulin pump therapy?
P2860
Q34419149-2B683AEB-A433-4862-BE31-54F5135548B3Q35772558-DAB00A88-4D06-46BD-9128-A4F1D5A5C46DQ36941696-7AE4D328-1ED4-419B-8020-9B11C14F8C6DQ37080658-52B66B1E-EFA9-4C85-8EE6-6B34D2DD31A2Q37671870-2AE1F5E8-5FF0-4C94-B00E-380D39BD624CQ38182669-CA090668-6F23-41C2-AA48-3476BF8B939AQ38320545-5086E68A-B630-4675-8BF3-57E076632CF5Q38596961-451F00EB-CC8F-410F-BB77-898B884580C4Q38816480-4E923E8F-E3C7-457D-9E4F-509EEC98EC13Q38885733-39489C68-CA3A-4876-959D-6BB5706F97E9Q40869844-609A62CC-2064-434D-B58B-1B8D090FF3B6Q50077356-6ED864C1-5072-45AE-AD25-B5393649E293Q53643195-5AB6963C-5514-4DA8-AC79-D4135FD5BF58
P2860
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@en
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@nl
type
label
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@en
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@nl
prefLabel
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@en
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@nl
P2093
P1476
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes.
@en
P2093
P304
P356
10.1111/J.1463-1326.2010.01239.X
P577
2010-10-01T00:00:00Z